[Bioequivalence studies of pharmaceutical preparations].
Bioequivalence studies are very important for the development of a pharmaceutical preparation in the pharmaceutical industry. Their rationale is the monitoring of pharmacokinetic and pharmacodynamic parameters after the administration of tested drugs. The target of such study is to evaluate the therapeutic compatibility of tested drugs (pharmaceutical equivalents or pharmaceutical alternatives). The importance of bioequivalence studies is increasing also due to the large growth of the production and consumption of generic products. Generic products represent approximately 50 % of the whole consumption in many European countries and USA. The search output of bioequivalence study is together with the pharmaceutical quality data of medical product one of the main part of the registration file submitted to a national regulatory authorities. The registration of generic products does not demand complicated and expensive clinical study contrary to original product. The comparison of the original and the generic product via bioequivalence study is suggested as sufficient. The aim of this article is to provide to a medical public a summary about the types of bioequivalence studies, their range, rules of their practise and let them gain their own attitude to this question.
Vetchý
D
D
Usta technologie léků, Farmaceutická fakulta, Veterinárni a farmaceutická univerzita, Brno. vetchy@email.cz
Frýbortová
K
K
Rabisková
M
M
Danecková
H
H
D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D016568:Drugs, Generic / Q000493:pharmacokinetics*; D006801:Humans; D013810:Therapeutic Equivalency
D016568:Drugs, Generic